Antioxidants & Redox Signaling

New Research Shows Potential Role for Mangos in Supporting Vascular Health and Antioxidant Activities

Retrieved on: 
Dienstag, August 1, 2023
SOD, GPX, United States National Library of Medicine, MedlinePlus, Mineral, PMID, Diet, College, American Society for Nutrition, VCAM1, Stroke, Public, Vascular disease, DV, VCAM-1, Nutrient, Woman, Risk, Glutathione peroxidase, Vitamin, National library, Oxidative stress, SOD1, Hydrogen peroxide, Superoxide dismutase, MD, Water, School, Phytochemical, Overweight, Copper, Antioxidants & Redox Signaling, Health, Science and technology in Asia, Death, Society, Conference, Disease, San Diego State University, Dietary supplement, Vaccine, Research, Exercise

BOSTON, Aug. 1, 2023 /PRNewswire/ -- Mangos are one of the most popular fruits1 in the world, grown in more than 100 countries2 globally and consumed by an extremely diverse population. Now, two new studies funded by the National Mango Board and presented as posters during the American Society for Nutrition's Annual Conference (Nutrition 2023) show mangos may play a role in risk reductions for vascular issues while helping to improve antioxidant levels among relatively healthy adult men and women who are overweight or obese.

Key Points: 
  • Mangos are one of the most popular fruits in the world, grown in 100+ countries and consumed by a diverse population.
  • "It's likely the unique matrix of vitamins and bioactive compounds synergistically working together that resulted in our findings," says Young Hong.
  • Following the first 12 weeks, participants took a 4-week washout break then switched groups and consumed the alternate snack for another 12 weeks.
  • Findings from the second study show a significant increase of glutathione peroxidase (GPX), a powerful antioxidant enzyme.

Vivid Microscopy's technology detects stages of cardiac microvascular disease using an animal-based model as demonstrated in a University of Louisville study

Retrieved on: 
Mittwoch, Oktober 26, 2022
Quality of life, Method, University of Louisville School of Medicine, Antioxidants & Redox Signaling, Woman, Vivid, Degenerative disease, Drug development, Cell, Mortality, Chest pain, Prof Bioresearch, University, Microscopy, Microangiopathy, CEO, Heart failure, CMD, Consequential damages, Heart, Biomarker, Glutathione, Microscope, Pharmaceutical industry, Medical imaging

WAUWATOSA, Wis., Oct. 26, 2022 /PRNewswire/ -- Vivid Microscopy, an emerging biotech company in the United States, today announced the successful use of its high content screening probe, SEMKUR-IM, in a study conducted by the University of Louisville on coronary microvascular disease (CMD) in post-menopausal women. 

Key Points: 
  • A disease impacting over 3 million women yearly, microvascular dysfunction often presents with chest pain and shortness of breath, which can lead to heart failure.
  • Early detection of the microvascular dysregulation signal is criticalif left undetected, it can lead to heart failure or a massive heart attack.
  • The University of Louisville's study has demonstrated how Vivid's probe can be used to ascertain the effectiveness of new cardiovascular treatments.
  • Using fluorescent technology to detect biomarkers associated with cellular injury, Vivid Microscopy has manufactured SEMKUR-IM, a quantitative test to evaluate cellular damage.